However, CSCs and hypoxia-adapted cancer cells may be less susceptible to small-molecule radiosensitizers due to the overexpression and high activity of membrane transporters ABCG2, ABCB1 and others that pump drugs out of the target cell. This evidence concerns the gene ABCB1 and cancer.